Today’s episode of The Qualys is from podcast #10 – Matt Kaeberlein, Ph.D.: rapamycin and dogs — man’s best friends? — living longer, healthier lives and turning back the clock on aging and age-related diseases.
Today’s episode of The Qualys is from podcast #26 – AMA #3: supplements, women’s health, patient care, and more.
Today’s episode of The Qualys is from podcast #09 – David Sabatini, M.D., Ph.D.: rapamycin and the discovery of mTOR — the nexus of aging and longevity?.
“We have to come to grasp the reality that there are problems in the medication system in generics, potentially even brand, and all sorts of holes that exist in how the system is now for medications. We want to be a part of that solution and work together to ensure that every patient is getting a high quality medication.” — David Light
There are not many topics in clinical medicine more polarizing than hormone replacement therapy (HRT) for women suffering from menopausal symptoms. Recently, The Lancet published a study finding “definite” excess risks of breast cancer associated with the use of HRT (with the exception of vaginal estrogen), and the issue included an accompanying editorial entitled “Menopausal hormones:…
“Generics are supposed to be this great leveler. It’s like the democratization of drugs that the rich and the poor alike can have access to for these great cures. To find out…that the companies cashing in on that image are really selling that short in a very devious way, is painful to realize. It’s a real great public health hope that has a very dark underbelly.” — Katherine Eban